Daniel M. Schmitt's most recent trade in Actuate Therapeutics Inc. was a trade of 204,285 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on April 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Actuate Therapeutics Inc | Daniel M. Schmitt | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 204,285 | 204,285 | - | - | Employee Stock Option (right to buy) | |
| Actuate Therapeutics Inc | Daniel M. Schmitt | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 66,503 | 66,503 | - | - | Employee Stock Option (right to buy) | |
| Actuate Therapeutics Inc | Daniel M. Schmitt | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 544,111 | 0 | - | - | Restricted Stock Units |